Aims: Heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNPA2/B1) is highly expressed in multiple types of tumor tissues and could potentially be used as a biomarker for the early detection of lung cancer. However, there is little evidence supporting its clinical significance as a prognostic marker in breast cancer.

中文翻译：

---

HnRNPA2 / B1是乳腺癌患者的新型预后生物标志物。

目的：异质核糖核蛋白A2 / B1（hnRNPA2 / B1）在多种类型的肿瘤组织中高度表达，有可能被用作早期检测肺癌的生物标志物。然而，几乎没有证据支持其作为乳腺癌预后标志物的临床意义。